Cargando…

Using positive deviance (PD) to reduce antibiotic resistant organisms: the Canadian PD project

Detalles Bibliográficos
Autores principales:	Reason, P, Rykert, L, Gardam, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239464/ http://dx.doi.org/10.1186/1753-6561-5-S6-O50

Ejemplares similares

Establishing a unique specimen repository with characterized G6PD enzyme activity for the development of new G6PD point-of-care tests
por: Kahn, Maria, et al.
Publicado: (2014)

Purging the HIV-1 reservoir through the disruption of the PD-1 pathway
por: DaFonseca, S, et al.
Publicado: (2010)

The global distribution of Plasmodium vivax and G6PD deficiency prevalence
por: Hay, Simon I
Publicado: (2012)

P267 Candida in the biliary tract: extrapolative PK PD considerations
por: Rege, Sujata, et al.
Publicado: (2022)

How is the positive deviance approach applied within healthcare organizations? A systematic review of methods used
por: Baxter, Ruth, et al.
Publicado: (2014)

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
por: Howes, Rosalind
Publicado: (2014)

The anti-tumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
por: Dovedi, Simon, et al.
Publicado: (2014)

Influence of CD38/PD1 co-expression on T cell subsets in HIV-TB co-infection
por: Sunder, Sharada Ramaseri, et al.
Publicado: (2012)

PD-L1 expression on monocytes marks active systemic lupus erythematosus in patients without nephritis
por: Stevens, Anne M, et al.
Publicado: (2012)

Planning for a publicity campaign on use of antibiotics and antibiotic resistance in Hong Kong
por: Ho, ML, et al.
Publicado: (2011)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

Corrective surgery for Parkinson's disease (PD) deformity following Deep Brain Stimulation (DBS) - Is DBS a last resort?
por: Mizutani, Jun, et al.
Publicado: (2015)

Virus-specific CD8+ T cells infiltrate melanoma lesions and retain function despite high PD-1 expression
por: Erkes, Dan A, et al.
Publicado: (2015)

Expansion of the reducing use of sedatives (RedUSe) project to Australian nursing homes
por: Westbury, Juanita, et al.
Publicado: (2014)

O036: Antibiotic resistance and molecular epidemiology of panton valentine leukocidin positive methicillin-resistant staphylococcus aureus (PVL+-MRSA): an international survey
por: Macedo-Vinas, M, et al.
Publicado: (2013)

S216: CD47/PD-L1 BISPECIFIC ANTIBODY (IBI322) IN ANTI-PD-1 OR PD-L1 TREATMENT-RESISTANT CLASSICAL HODGKIN LYMPHOMA: A PHASE I STUDY
por: Zhang, Huilai, et al.
Publicado: (2023)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer
por: Dhodapkar, Kavita, et al.
Publicado: (2014)

Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment
por: Spranger, Stefani, et al.
Publicado: (2013)

Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
por: Callahan, Margaret K, et al.
Publicado: (2013)

P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis
por: Soman, Rajeev, et al.
Publicado: (2022)

Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
por: Postow, Michael A, et al.
Publicado: (2014)

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1
por: Kohrt, Holbrook, et al.
Publicado: (2013)

O008: A multidisciplinary initiative to save antibiotics: the world alliance against antibiotic resistance (WAAR)
por: Carlet, J, et al.
Publicado: (2013)

Final database lock results of the phase 2 cohort of lenvatinib + pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma
por: Lee, Chung-Han, et al.
Publicado: (2023)

PD-L1 expression correlates with immune response in a Phase I trial of CCL21 gene modified dendritic cell therapy in lung cancer
por: Lee, Jay M, et al.
Publicado: (2014)

A program for audit of infections and antibiotic resistance in critical ill
por: Hanberger, HS-I, et al.
Publicado: (2011)

A novel peptide therapeutic targeting PD1 immune checkpoint with equipotent antagonism of both ligands and a potential for better management of immune-related adverse events
por: Sasikumar, Pottayil, et al.
Publicado: (2013)

PD-1, IL-10, IFN-γ and IL-12 form a network to regulate HIV-1-specific CD4 T Cell and antigen-presenting cell function
por: Porichis, F, et al.
Publicado: (2012)

Assessing the burden of musculoskeletal conditions: a joint World Health Organization–Bone and Joint Decade project
por: Khaltaev, N, et al.
Publicado: (2003)

Using linked healthcare data to create a randomised controlled trial: the rapid trial (reducing antibiotic prescribing in dentistry)
por: Elouafkaoui, Paula, et al.
Publicado: (2013)

Outcomes of adolescents treated involuntarily under the Canadian mental health act
por: Cawthorpe, David, et al.
Publicado: (2007)

O015 Sleep, Stress, and Cognitive Fatigue in Canadian Wildland Firefighters
por: Wallace-Webb, J, et al.
Publicado: (2022)

Dissecting the tumor micro-environment in triple negative breast cancer identifies a mutually exclusive expression pattern of the immune co-inhibitory molecules B7-H4 and PD-L1
por: Shaffer, Donald R, et al.
Publicado: (2015)

Using Positive Deviance to reduce medication errors in a tertiary care hospital
por: Ferracini, Fabio Teixeira, et al.
Publicado: (2016)

The relationship between the antibiotic consumption in hospitals and the community and the selection of methicillin-resistant Staphylococcus aureus
por: Kardaś-Słoma, L, et al.
Publicado: (2011)

WS1.2: USE OF ANTIBIOTICS IN COVID-19 PATIENTS AND ANTIBACTERIAL RESISTANCE PATTERN- A COUNTRYWIDE PICTURE
por: Paul, Shrebash, et al.
Publicado: (2022)

The Sloane Project
por: Bishop, H
Publicado: (2004)

Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment
por: Horton, Brendan, et al.
Publicado: (2015)

Research in tree genetic engineering; the Canadian context for field trial of GM trees
por: Séguin, Armand
Publicado: (2011)

P481 Antifungal vaccines: An alternative approach to combat multidrug resistance in the post-antibiotic era
por: Ahmad, Aijaz
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iq3rbk3ue8rmtt5vqlv5oeq56u